Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-12-025631)

Filing Details

Accession Number:: 0001140361-12-025631
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-05-16 10:29:13
Reporting Period:: 2012-05-16

Filing Date:: 2012-05-16
Accepted Time:: 2012-05-16 09:29:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1080014	Theravance Inc	THRX	Pharmaceutical Preparations (2834)	943265960

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1131399	Plc Glaxosmithkline	980 Great West Road Brentford Middlesex X0 TW8 9GS		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-05-16	10,000,000	$21.29	25,814,421	No	4	P	Indirect	By Corporation

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Corporation

Footnotes

Common stock purchased pursuant to the Common Stock Purchase Agreement by and among Theravance, Inc. (the "Issuer"), GlaxoSmithKline LLC and Glaxo Group Limited ("GGL"), dated as of April 2, 2012, pursuant to which the Issuer agreed to issue and sell and GGL agreed to purchase 10,000,000 shares of Common Stock.
Shares of Common Stock are held of record by GGL.